Laddar...
Microfluidics in Malignant Glioma Research and Precision Medicine
Glioblastoma multiforme (GBM) is an aggressive form of brain cancer that has no effective treatments and a prognosis of only 12–15 months. Microfluidic technologies deliver microscale control of fluids and cells, and have aided cancer therapy as point-of-care devices for the diagnosis of breast and...
Sparad:
| I publikationen: | Adv Biosyst |
|---|---|
| Huvudupphovsmän: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5959050/ https://ncbi.nlm.nih.gov/pubmed/29780878 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/adbi.201700221 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|